Literature DB >> 29293475

Pharmacokinetics and pharmacodynamics of antibiotics in central nervous system infections.

Roland Nau1,2, Jana Seele1,2, Marija Djukic1,2, Helmut Eiffert3.   

Abstract

PURPOSE OF REVIEW: The barriers surrounding the central nervous system (CNS) together with the emergence of multiresistant pathogens pose a therapeutic challenge for the effective treatment of CNS infections. RECENT
FINDINGS: In addition to vancomycin, colistin and aminoglycosides, classically used for intrathecal injection, drug concentrations in cerebrospinal fluid after intrathecal injection of daptomycin and tigecyclin were recently studied.
SUMMARY: The entry of antiinfectives into the CNS compartments is determined by the physicochemical properties of the drug and by conditions in the host. The most important drug properties are lipophilicity at a neutral pH, molecular mass and drug binding to serum proteins. In clinical practice, active transport is of importance only for some drugs. In recent years, intrathecal injection of antiinfectives in addition to systemic therapy has regained attention as a means to achieve high cerebrospinal fluid concentrations. The classification of antibacterials and antifungals into time-dependent and concentration-dependent compounds is also valid for the CNS compartments.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29293475     DOI: 10.1097/QCO.0000000000000418

Source DB:  PubMed          Journal:  Curr Opin Infect Dis        ISSN: 0951-7375            Impact factor:   4.915


  8 in total

Review 1.  Brain abscess in pediatric age: a review.

Authors:  Chiara Mameli; Teresa Genoni; Cristina Madia; Chiara Doneda; Francesca Penagini; Gianvincenzo Zuccotti
Journal:  Childs Nerv Syst       Date:  2019-05-06       Impact factor: 1.475

2.  Understanding central nervous system efficacy of antimicrobials.

Authors:  Pierre Tattevin; Tom Solomon; Matthijs C Brouwer
Journal:  Intensive Care Med       Date:  2018-06-23       Impact factor: 17.440

Review 3.  Intrathecal Antibacterial and Antifungal Therapies.

Authors:  Roland Nau; Claudia Blei; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

4.  Pharmacotherapy alleviates pathological changes in human direct reprogrammed neuronal cell model of myotonic dystrophy type 1.

Authors:  Mougina K Eltahir; Masayuki Nakamori; Satoshi Hattori; Takashi Kimura; Hideki Mochizuki; Seiichi Nagano
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

5.  Sequential intraventricular injection of tigecycline and polymyxin B in the treatment of intracranial Acinetobacter baumannii infection after trauma: a case report and review of the literature.

Authors:  Li Zhong; Xue-Zhi Shi; Lei Su; Zhi-Feng Liu
Journal:  Mil Med Res       Date:  2020-05-10

6.  A case report of intraventricular and intrathecal tigecycline infusions for an extensively drug-resistant intracranial Acinetobacter baumannii infection.

Authors:  Zi-Wei Deng; Jin Wang; Cheng-Feng Qiu; Yi Yang; Zhi-Hua Shi; Jian-Liang Zhou
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

Review 7.  Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review.

Authors:  Anselm Jorda; Markus Zeitlinger
Journal:  Clin Pharmacokinet       Date:  2020-09       Impact factor: 6.447

8.  UPLC-MS/MS Method for Simultaneous Determination of 14 Antimicrobials in Human Plasma and Cerebrospinal Fluid: Application to Therapeutic Drug Monitoring.

Authors:  Huiting Sun; Han Xing; Xueke Tian; Xiaojian Zhang; Jing Yang; Peile Wang
Journal:  J Anal Methods Chem       Date:  2022-01-05       Impact factor: 2.193

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.